Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents by Howard, Amber E
Synthesis and evaluation of carbocyanine dyes as PRMT inhibitors and imaging agents 
 
Amber E. Howard1, Eric A. Owens1, Andrew R. Levitz1, Leilei Yan1, You Feng1, Yujun George 
Zheng1,* and Maged Henary1,*  
1 Department of Chemistry, Georgia State University 
Atlanta, GA 30303, USA 
*Principal Investigator 
Introduction   
Protein arginine methyltransferase (PRMT) promotes cancer-causing post-translational 
modifications and has been recognized as a target for developing anti-cancer therapeutics. 
Arginine methylation is facilitated by PRMTs that use S-adenosyl-L-methionine as the methyl 
donor to modify the guanidinium side chain of specific arginine residues, which results in mono- 
and di-methylated arginine residues. Small chemical probes that target PRMTs with strong 
affinity and selectivity can be used to reveal biological mechanisms of arginine methylation and 
establish the role of PRMT proteins in a disease pathway. The purpose of this study was to 
synthesize and evaluate monocationic trimethine cyanine compounds that have potential 
application in PRMT studies as enzyme inhibitors and as contrast agents for fluorescence 
microscopy. 
 
Methods 
Through the synthetic modification of trimethine cyanine dyes, several hydrophobic derivatives 
were developed in good yields utilizing ethyl, butyl, and phenylpropyl halides for nitrogen 
alkylation of the heterocyclic moieties. These cyanine compounds were investigated by 
screening their anti-methyltransferase activity. The degree of diminishment in PRMT activity 
was used as a parameter to evaluate the potency of the compounds in inhibiting PRMT1 and 
PRMT5-mediated arginine methylation. The IC50 values of the most promising inhibitors were 
derived from the dose response curve as the concentration of half-inhibition. Optical and 
fluorescent microscopies, cell proliferation and flow cytometry assays were used to study the 
functions of the most potent compounds. 
 
Results 
Several of the trimethine cyanine compounds synthesized for this study showed low-micromolar 
anti-PRMT1 and anti-PRMT5 activity. The promising IC50 values are currently helping us 
generate a structure-activity relationship (SAR) for the general cyanine scaffold for developing 
more potent anti-cancer agents. 
 
Conclusion 
Because PRMT proteins impact a number of disease pathways, the development of novel potent 
small molecule inhibitors of PRMTs is highly desired. Carbocyanine molecules containing 
different heterocylic moieties and hydrophobic substituents have been synthesized and several 
possess micromolar potency for PRMT1 and PRMT5 inhibition that should be further 
investigated to develop nanomolar inhibitors. 
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